Kick-start Your Education: 2018 SPS Continuing Education Courses


Dear Colleagues,

The 2018 SPS Annual Meeting provides a dynamic forum for sharing the latest in safety pharmacology. The meeting will kick off on Sunday, September 30, 2018 with a full day of Continuing Education courses, offering a variety of education topics:

  • AM1—CiPA Components in Early Cardiovascular Safety Assessment
  • AM2—SENDing Safety Pharmacology into the Future
  • AM3—Diurnal/Circadian Rhythm and Female vs Male Preclinical Assessment in Drug Development
  • Afternoon Mini-Course: Tools to Train Safety Pharmacologists to Deliver Reproducible Data
  • PM1—Advanced Topics in Safety Pharmacology: Clinical Translation Case Studies in Central Nervous System, Cardiovascular, and Respiratory
  • PM2—Safety Assessment of Oligonucleotides and Gene Therapy Including Gene Editing with CRISPR/Cas9
  • PM3—Advanced Central Nervous System Models: Issue Resolution and Clinical Translation 

If you have not previously registered for the Meeting, please register by July 15 to take advantage of the early bird registration rate. If you have previously registered for the Meeting and would like to add a CE course or the Afternoon Mini-Course, please click here or mail/fax the registration form to SPS Headquarters. 

We look forward to seeing you in Washington, DC for the safety pharmacology event of the year! 


Safety Pharmacology Society Headquarters

11190 Sunrise Valley Drive, Suite 300
Reston, VA 20191
(703) 547-0874
(703) 438-3113 (f)

Recent Stories
ICH E14/S7B Q&As: Public Comment Closes Soon!

Webinar of Interest! An Update on COVID-19: Basic and Clinical Perspectives

Congratulations 2021 Incoming Board Members!